VFWSX
Price
$117.36
Change
-$0.57 (-0.48%)
Updated
Dec 17 closing price
VTPSX
Price
$131.55
Change
-$0.68 (-0.51%)
Updated
Dec 17 closing price
Ad is loading...

VFWSX vs VTPSX

Header iconVFWSX vs VTPSX Comparison
Open Charts VFWSX vs VTPSXBanner chart's image
Vanguard FTSE All-Wld ex-US Idx Instl
Price$117.36
Change-$0.57 (-0.48%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Idx InstlPls
Price$131.55
Change-$0.68 (-0.51%)
VolumeN/A
CapitalizationN/A
VFWSX vs VTPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VFWSX vs. VTPSX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VFWSX is a Buy and VTPSX is a Buy.

FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 443B vs. VFWSX (58.2B). VFWSX (3.34) and VTPSX (3.30) have matching dividends . VFWSX was incepted earlier than VTPSX: VFWSX (18 years) vs VTPSX (14 years). VFWSX (4.00) and VTPSX (4.00) have comparable annual turnover. VFWSX has a lower initial minimum investment than VTPSX: VFWSX (5000000) vs VTPSX (100000000). VFWSX (9.13) and VTPSX (8.83) have marching annual gain over last year. VFWSX (14.12) and VTPSX (14.02) have equivalent 5 years return.
VFWSXVTPSXVFWSX / VTPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years14 years-
Gain YTD6.4156.077106%
Front LoadN/AN/A-
Min. Initial Investment50000001000000005%
Min. Initial Investment IRAN/AN/A-
Net Assets58.2B443B13%
Annual Yield % from dividends3.343.30101%
Returns for 1 year9.138.83103%
Returns for 3 years1.751.10158%
Returns for 5 years14.1214.02101%
Returns for 10 years35.1235.8398%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PERF2.270.12
+5.58%
Perfect Corp
RCKT11.920.16
+1.36%
Rocket Pharmaceuticals
KRG25.99-0.15
-0.57%
Kite Realty Group Trust
GLW47.76-0.42
-0.87%
Corning
LTRN3.43-0.13
-3.65%
Lantern Pharma